Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
LA Jolla Pharma
(NQ:
LJPC
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 19, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about LA Jolla Pharma
Innoviva Completes Acquisition of La Jolla Pharmaceutical
August 22, 2022
From
Innoviva, Inc.
Via
Business Wire
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders
July 28, 2022
From
Halper Sadeh LLP
Via
Business Wire
LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC
July 11, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders
July 11, 2022
From
Halper Sadeh LLP
Via
Business Wire
Innoviva to Acquire La Jolla Pharmaceutical Company
July 11, 2022
From
La Jolla Pharmaceutical Company
Via
Business Wire
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress
May 16, 2022
From
La Jolla Pharmaceutical Company
Via
Business Wire
La Jolla Pharmaceutical Company Announces Share Repurchase Plan
November 17, 2021
From
La Jolla Pharmaceutical Company
Via
Business Wire
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate Progress
November 04, 2021
From
La Jolla Pharmaceutical Company
Via
Business Wire
Tony Hodges, M.D., FACP, FCCP, Appointed Chief Medical Officer of La Jolla Pharmaceutical Company
September 10, 2021
From
La Jolla Pharmaceutical Company
Via
Business Wire
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate Progress
August 05, 2021
From
La Jolla Pharmaceutical Company
Via
Business Wire
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Corporate Progress
May 07, 2021
From
La Jolla Pharmaceutical Company
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.